Tomeki

Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development

Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development

is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991.

By United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy

0 (0 Ratings)
0 Want to read0 Currently reading0 Have read

Publish Date

1992

Publisher

U.S. G.P.O.,For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office

Language

eng

Pages

503